We are analyzing https://link.springer.com/article/10.1007/s00268-011-1411-1.

Title:
Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer | World Journal of Surgery
Description:
An elevation in the neutrophil-to-lymphocyte ratio (NLR) has been shown to be associated with a poorer prognosis in patients with various tumors. The aim of this retrospective study was to clarify the correlation of the pretherapeutic NLR with the prognostic value of the pathologic response to neoadjuvant chemotherapy (NAC) in patients with advanced esophageal cancer. This study was a retrospective review of 83 patients undergoing NAC for advanced esophageal cancer following esophagectomy. The NLR was measured before NAC, and the pathologic responses to NAC were evaluated. A comparison was performed for those whose pathology responded (responders) (G3/G2/G1b) and nonresponders (G1a/G0). In a univariate analysis, the cStage (P = 0.005), cN (P = 0.0001), and NLR (P = 0.005) were statistically significant parameters. A multivariate analysis revealed that the factors independently associated with pathologic responses were the pretreatment NLR (<2.2/≥2.2) (P = 0.043) and lymph nodes metastasis (P = 0.002). The pretreatment NLR (<2.2/≥2.2) was found to be a statistically significant useful predictive marker for a pathologic response (P = 0.001). The pathologic response rates were 56% in the patients with an NLR <2.2 and 21% in patients with an NLR of ≥2.2. Our study is the first to demonstrate that the pretherapeutic NLR can be used as a predictor for chemosensitivity of thoracic esophageal cancer. Preoperative evaluation based on the clinical N stage and NLR may be easily used in routine clinical practice.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, cancer, google, scholar, pubmed, cas, esophageal, surg, response, patients, chemotherapy, cell, carcinoma, ratio, neoadjuvant, nlr, preoperative, squamous, pathologic, prognostic, esophagus, oncol, surgery, advanced, clinical, predicts, randomized, trial, privacy, cookies, content, journal, pretherapeutic, lymphocyte, sato, survival, oesophageal, resection, postoperative, creactive, protein, information, publish, research, search, world, correlation, neutrophil, hiroshi, neutrophiltolymphocyte,

Topics {✒️}

inflammation-based prognostic score serum c-reactive protein month download article/chapter inoperative gastro-oesophageal cancer squamous cell carcinoma jp/professional/statistics/statistics androgen-independent prostate cancer pretherapeutic d-dimer levels predicting long-term mortality c-reactive protein pre-operative elevated neutrophil oesophageal cancer resection advanced esophageal cancer independent prognostic variable independent prognostic indicator pathologic response rates full article pdf privacy choices/manage cookies predict pathologic response thoracic esophageal cancer article world journal phase ii trial c-erb b-2 predicts postoperative outcome surgery hiroshi sato oesophageal cancer mcmillan dc national cancer center routine clinical practice european economic area g3/g2/g1b lymph nodes metastasis check access randomized clinical trials percutaneous coronary intervention halazun kj tumor metabolic activity omega-3 fatty acids instant access preoperative evaluation based esophageal cancer conditions privacy policy pathologic response article sato prognostic factor randomized clinical trial long-term results neutrophil-lymphocyte ratio randomized controlled trial elective gastrointestinal surgery

Questions {❓}

Akbarshahi H, Andersson B, Norden M et al (2008) Perioperative nutrition in elective gastrointestinal surgery: potential for improvement?
Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer
         description:An elevation in the neutrophil-to-lymphocyte ratio (NLR) has been shown to be associated with a poorer prognosis in patients with various tumors. The aim of this retrospective study was to clarify the correlation of the pretherapeutic NLR with the prognostic value of the pathologic response to neoadjuvant chemotherapy (NAC) in patients with advanced esophageal cancer. This study was a retrospective review of 83 patients undergoing NAC for advanced esophageal cancer following esophagectomy. The NLR was measured before NAC, and the pathologic responses to NAC were evaluated. A comparison was performed for those whose pathology responded (responders) (G3/G2/G1b) and nonresponders (G1a/G0). In a univariate analysis, the cStage (P = 0.005), cN (P = 0.0001), and NLR (P = 0.005) were statistically significant parameters. A multivariate analysis revealed that the factors independently associated with pathologic responses were the pretreatment NLR (<2.2/≥2.2) (P = 0.043) and lymph nodes metastasis (P = 0.002). The pretreatment NLR (<2.2/≥2.2) was found to be a statistically significant useful predictive marker for a pathologic response (P = 0.001). The pathologic response rates were 56% in the patients with an NLR <2.2 and 21% in patients with an NLR of ≥2.2. Our study is the first to demonstrate that the pretherapeutic NLR can be used as a predictor for chemosensitivity of thoracic esophageal cancer. Preoperative evaluation based on the clinical N stage and NLR may be easily used in routine clinical practice.
         datePublished:2012-01-06T00:00:00Z
         dateModified:2012-01-06T00:00:00Z
         pageStart:617
         pageEnd:622
         sameAs:https://doi.org/10.1007/s00268-011-1411-1
         keywords:
            Esophageal Cancer
            Esophageal Squamous Cell Carcinoma
            Pathologic Response
            Glasgow Prognostic Score
            Total Lymphocyte Count
            Surgery
            Abdominal Surgery
            Cardiac Surgery
            General Surgery
            Thoracic Surgery
            Vascular Surgery
         image:
         isPartOf:
            name:World Journal of Surgery
            issn:
               1432-2323
               0364-2313
            volumeNumber:36
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hiroshi Sato
               affiliation:
                     name:Shizuoka Cancer Center Hospital
                     address:
                        name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
                        type:PostalAddress
                     type:Organization
                     name:Tokyo Medical and Dental University
                     address:
                        name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yasuhiro Tsubosa
               affiliation:
                     name:Shizuoka Cancer Center Hospital
                     address:
                        name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tatsuyuki Kawano
               affiliation:
                     name:Tokyo Medical and Dental University
                     address:
                        name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer
      description:An elevation in the neutrophil-to-lymphocyte ratio (NLR) has been shown to be associated with a poorer prognosis in patients with various tumors. The aim of this retrospective study was to clarify the correlation of the pretherapeutic NLR with the prognostic value of the pathologic response to neoadjuvant chemotherapy (NAC) in patients with advanced esophageal cancer. This study was a retrospective review of 83 patients undergoing NAC for advanced esophageal cancer following esophagectomy. The NLR was measured before NAC, and the pathologic responses to NAC were evaluated. A comparison was performed for those whose pathology responded (responders) (G3/G2/G1b) and nonresponders (G1a/G0). In a univariate analysis, the cStage (P = 0.005), cN (P = 0.0001), and NLR (P = 0.005) were statistically significant parameters. A multivariate analysis revealed that the factors independently associated with pathologic responses were the pretreatment NLR (<2.2/≥2.2) (P = 0.043) and lymph nodes metastasis (P = 0.002). The pretreatment NLR (<2.2/≥2.2) was found to be a statistically significant useful predictive marker for a pathologic response (P = 0.001). The pathologic response rates were 56% in the patients with an NLR <2.2 and 21% in patients with an NLR of ≥2.2. Our study is the first to demonstrate that the pretherapeutic NLR can be used as a predictor for chemosensitivity of thoracic esophageal cancer. Preoperative evaluation based on the clinical N stage and NLR may be easily used in routine clinical practice.
      datePublished:2012-01-06T00:00:00Z
      dateModified:2012-01-06T00:00:00Z
      pageStart:617
      pageEnd:622
      sameAs:https://doi.org/10.1007/s00268-011-1411-1
      keywords:
         Esophageal Cancer
         Esophageal Squamous Cell Carcinoma
         Pathologic Response
         Glasgow Prognostic Score
         Total Lymphocyte Count
         Surgery
         Abdominal Surgery
         Cardiac Surgery
         General Surgery
         Thoracic Surgery
         Vascular Surgery
      image:
      isPartOf:
         name:World Journal of Surgery
         issn:
            1432-2323
            0364-2313
         volumeNumber:36
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hiroshi Sato
            affiliation:
                  name:Shizuoka Cancer Center Hospital
                  address:
                     name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
                     type:PostalAddress
                  type:Organization
                  name:Tokyo Medical and Dental University
                  address:
                     name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yasuhiro Tsubosa
            affiliation:
                  name:Shizuoka Cancer Center Hospital
                  address:
                     name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tatsuyuki Kawano
            affiliation:
                  name:Tokyo Medical and Dental University
                  address:
                     name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:World Journal of Surgery
      issn:
         1432-2323
         0364-2313
      volumeNumber:36
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shizuoka Cancer Center Hospital
      address:
         name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
         type:PostalAddress
      name:Tokyo Medical and Dental University
      address:
         name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
         type:PostalAddress
      name:Shizuoka Cancer Center Hospital
      address:
         name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
         type:PostalAddress
      name:Tokyo Medical and Dental University
      address:
         name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hiroshi Sato
      affiliation:
            name:Shizuoka Cancer Center Hospital
            address:
               name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
               type:PostalAddress
            type:Organization
            name:Tokyo Medical and Dental University
            address:
               name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yasuhiro Tsubosa
      affiliation:
            name:Shizuoka Cancer Center Hospital
            address:
               name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
               type:PostalAddress
            type:Organization
      name:Tatsuyuki Kawano
      affiliation:
            name:Tokyo Medical and Dental University
            address:
               name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
      name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
      name:Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan
      name:Department of Esophago-Gastric Surgery, Tokyo Medical and Dental University, Tokyo, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(106)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.11s.

LINK . SPRINGER . COM {}